Targeted Therapies Coincided With Dramatic Decline in Multiple Myeloma Mortality in the US

Oncotarget by Oncotarget Podcast

Multiple myeloma is the second most common blood cancer in the United States and has long been considered a difficult disease to treat. For decades, treatment options were limited, and survival remained poor. However, th...View more